← back to search

Man Jiang

Harbin Medical University · CN
Area of research
Oncology · Inorganic Chemistry
Research interest
Research focused on Nitazoxanide and Niclosamide, with related work in Cell biology, Pharmacology, Mitochondrion. Notable publications include 'Piezo1 channel activation stimulates ATP production through enhancing mitochondrial respiration and glycolysis in vascular endothelial cells', 'Synthesis of Flowerlike g‐C 3 N 4 /BiOBr with Enhanced Visible Light Photocatalytic Activity for Dye Degradation', and 'The different response of cardiomyocytes and cardiac fibroblasts to mitochondria inhibition and the underlying role of STAT3'.
h-index
citations
277
works
10
NIH funding
primary concept
email

Recent publications

Inhibition of ULK1 attenuates ferroptosis-mediated cardiac hypertrophy via HMGA2/METTL14/SLC7A11 axis in mice
European Journal of Pharmacology 2025cited by 4position: middledoi
LncRNA Gm15834 Aggravates Cardiac Hypertrophy by Interacting with Sam68 and Activating NF-κB Mediated Inflammation
Cardiovascular Drugs and Therapy 2024cited by 2position: middledoi
Piezo1 channel activation stimulates ATP production through enhancing mitochondrial respiration and glycolysis in vascular endothelial cells
British Journal of Pharmacology 2023cited by 58position: firstdoi
Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis
British Journal of Pharmacology 2023cited by 15position: middledoi
Mitophagy Activation Targeting PINK1 Is an Effective Treatment to Inhibit Zika Virus Replication
ACS Infectious Diseases 2023cited by 14position: middledoi
Repurposing nitazoxanide as a novel anti‐atherosclerotic drug based on mitochondrial uncoupling mechanisms
British Journal of Pharmacology 2022cited by 32position: middledoi
Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice
Acta Pharmaceutica Sinica B 2021cited by 48position: middledoi
Anthelmintic niclosamide attenuates pressure-overload induced heart failure in mice
European Journal of Pharmacology 2021cited by 17position: middledoi
The different response of cardiomyocytes and cardiac fibroblasts to mitochondria inhibition and the underlying role of STAT3
Basic Research in Cardiology 2019cited by 52position: middledoi
Synthesis of Flowerlike g‐C<sub>3</sub>N<sub>4</sub>/BiOBr with Enhanced Visible Light Photocatalytic Activity for Dye Degradation
European Journal of Inorganic Chemistry 2018cited by 58position: firstdoi
Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries
British Journal of Pharmacology 2018cited by 35position: middledoi
Template-free fabrication of porous CuCo2O4 hollow spheres and their application in lithium ion batteries
Journal of Solid State Electrochemistry 2016cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

De‐Li Dong · China Pharmaceutical University6 papers (2018–2023)Zhi‐Jie Sun · Harbin Medical University4 papers (2018–2023)Yan‐Chao Dong · Harbin Medical University3 papers (2022–2023)Nan Hu · Hubei University of Medicine3 papers (2018–2021)Jin‐Lai Gao · Harbin Medical University3 papers (2018–2021)Wen‐Jie Bu · Harbin Medical University3 papers (2022–2023)Minghui Ma · Harbin Medical University3 papers (2019–2021)Ming Cao · Harbin Medical University2 papers (2021–2023)Xuyang Chen · Harbin Medical University2 papers (2021–2023)Yao Fu · Qingdao University2 papers (2019–2021)Jing Zhao · Tianjin University of Traditional Chinese Medicine2 papers (2019–2021)Hongli Sun · Indiana University School of Medicine2 papers (2024–2025)Wenfeng Li · Shandong University2 papers (2021–2022)Meitian Zhang · Harbin Medical University2 papers (2024–2025)Yixin Zhang · Ningbo University2 papers (2021–2023)Fengfeng Li · Harbin Medical University2 papers (2021–2022)Qianhui Zhang · South China Agricultural University2 papers (2024–2025)Pilong Shi · Harbin Medical University2 papers (2024–2025)Zhijie Sun · Harbin Medical University2 papers (2021–2021)Kai Liu · Harbin Medical University1 papers (2024–2024)